Top

Experimental Obesity Drug SuppressesFood Cravings

July 21, 2009

There is a new diet drug making waves due to the way that it attacks the craving center of the body to promote weight loss
Boston (DbTechNo) - There is a new diet drug making waves due to the way that it attacks the craving center of the body to promote weight loss.

According to the drug’s makers, their experimental drug known as Contrave has proven very effective when it comes to helping people lose unwanted fat.

The drug is a combination pill, made up of anti-depression and smoking cessation drugs.

Study results featuring the drug resulted in an average of 8% weight loss in study participants, lofty numbers for sure.

The only real side effects associated with the drug were head ache, constipation and nausea.

Makers of the drug actually say that their drug actually exceeds FDA recommended guidelines for obesity drugs.

“This is the first drug, that I know of, that addressed the craving issue,” said Dr. Dennis Kim, senior vice president of medical affairs and communications at Orexigen Therapeutics Inc., one of the drug’s manufacturers.

“We have clearly cleared the hurdle, the efficacy benchmark, it’s of course the FDA’s judgment to see if it passes for safety,” Kim added.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists

Comments


All comments are moderated.
If your comment is approved, it will be posted within 24 hours





Breaking News

Lady Gaga Monster Ball Tour Coming to Montreal

Boston (DbTechNo) - The one and only Lady Gaga has just revealed plans for a 31 concert North American tour this summer. Her... 

March 15, 2010 |

Toronto Not Paying For Corey Haim Funeral

Boston (DbTechNo) - A spokesman for the city of Toronto has stated that the city will not be paying for the funeral of the... 

March 15, 2010 |

Merck Blood Thinner Outperforms Warfarin in Clinical Trial

Boston (DbTechNo) - Betrixaban is the name of a new blood thinner from merck that performed very well in a clinical trial... 

March 15, 2010 |

Bottom